Overall (N = 112) | Bridge-ECMO group (n = 27) | Non-bridge-ECMO group (n = 85) | p | |
---|---|---|---|---|
Demographics | ||||
Age, y | 58.0 [52.5–62.0] | 58.0 [53.0–62.0] | 58.0 [52.0–62.0] | 0.859 |
Sex (Male) | 71 (63.4%) | 21 (77.8%) | 50 (58.8%) | 0.121 |
BMI (kg/m2) | 21.2 [19.0–23.5] | 21.4 [18.7–23.4] | 21.2 [19.1–23.5] | 0.999 |
Primary diagnosis, n (%) | 0.187 | |||
Idiopathic pulmonary fibrosis | 60 (53.6%) | 13 (48.1%) | 47 (55.3%) | |
Other fibrosis/Emphysema | 7 (6.2%) | 1 (3.7%) | 6 (7.1%) | |
CTD related interstitial lung disease | 20 (17.9%) | 5 (18.5%) | 15 (17.6%) | |
Bronchiolitis obliterans after HSCT | 10 (8.9%) | 2 (7.4%) | 8 (9.4%) | |
Acute respiratory distress syndrome | 8 (7.1%) | 5 (18.5%) | 3 (3.5%) | |
Othersa | 7 (6.2%) | 1 (3.7%) | 6 (7.1%) | |
Pre-transplantation status | ||||
PaO2/FiO2 ratio | 224.0 [125.0–281.0] | 110.0 [82.5–251.0] | 229.0 [181.0–288.0] | 0.008 |
LVEF, % | 62.0 [59.0–67.0] | 61.0 [56.0–65.0] | 63.0 [59.0–68.0] | 0.298 |
RVSP, mmHg | 50.0 [41.0–66.0] | 61.0 [47.0–88.0] | 48.5 [40.5–64.5] | 0.141 |
Preoperative MV, n (%) | 39 (34.8%) | 27 (100.0%) | 12 (14.1%) | < 0.001 |
Wait-list duration (day) | 69.5 [18.5–127.5] | 27.0 [10.5–40.5] | 87.0 [35.0–145.0] | < 0.001 |
Donor demographics | ||||
Sex (Male) | 66 (58.9%) | 16 (59.3%) | 50 (58.8%) | 1.000 |
Age, y | 41.5 [32.0–49.0] | 38.0 [33.5–47.0] | 43.0 [31.0–50.0] | 0.464 |
BMI (kg/m2) | 22.1 [20.1–24.2] | 20.9 [20.0–23.2] | 22.7 [20.1–25.1] | 0.122 |
Donor cause of brain death, n (%) | 0.053 | |||
Trauma | 37 (33.0%) | 12 (44.4%) | 25 (29.4%) | |
Underlying disease progression | 27 (24.1%) | 8 (29.6%) | 19 (22.4%) | |
Suicide | 25 (22.3%) | 7 (25.9%) | 18 (21.2%) | |
Donor current smoker, n (%) | 46 (41.1%) | 7 (25.9%) | 39 (45.9%) | 0.043 |